S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:ITCI

Intra-Cellular Therapies Insider Trades

$57.88
+0.15 (+0.26%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$55.55
$59.85
50-Day Range
$43.00
$65.64
52-Week Range
$28.40
$66.00
Volume
873,853 shs
Average Volume
1.08 million shs
Market Capitalization
$5.46 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.28

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
13.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$42.40 M

Insider Buying and Selling by Quarter

Get ITCI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Intra-Cellular Therapies (NASDAQ:ITCI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2022Joel S MarcusDirectorSell10,000$55.00$550,000.0054,233  
4/8/2022Mark NeumannEVPSell86,348$64.37$5,558,220.7645,339  
3/18/2022Rory B RiggsDirectorSell20,637$61.18$1,262,571.66  
3/16/2022Rory B RiggsDirectorSell64,534$59.27$3,824,930.18  
3/7/2022Joel S MarcusDirectorSell5,000$54.52$272,600.00  
3/4/2022Suresh K DurgamInsiderSell3,860$55.52$214,307.20  
3/2/2022Suresh K DurgamInsiderSell4,177$56.98$238,005.46  
2/24/2022Lawrence J HinelineCFOSell7,454$51.97$387,384.38  
2/24/2022Mark NeumannEVPSell7,906$52.21$412,772.26  
2/24/2022Sharon MatesCEOSell22,589$51.98$1,174,176.22  
2/24/2022Suresh K DurgamInsiderSell4,046$52.27$211,484.42  
2/22/2022Lawrence J HinelineCFOSell10,443$55.40$578,542.20  
2/22/2022Mark NeumannEVPSell11,139$55.29$615,875.31  
2/22/2022Sharon MatesCEOSell27,847$55.39$1,542,445.33  
2/22/2022Suresh K DurgamInsiderSell4,177$55.29$230,946.33  
1/18/2022Suresh K DurgamInsiderSell6,223$42.03$261,552.69  
1/10/2022Lawrence J HinelineCFOSell19,639$40.76$800,485.64  
1/10/2022Mark NeumannEVPSell20,948$40.78$854,259.44  
1/10/2022Sharon MatesCEOSell41,896$40.78$1,708,518.88  
1/10/2022Suresh K DurgamInsiderSell6,870$40.76$280,021.20  
12/21/2021Lawrence J HinelineCFOSell175,000$47.59$8,328,250.00  
12/21/2021Michael HalsteadEVPSell176,863$47.56$8,411,604.28  
10/18/2021Mark NeumannEVPSell13,448$40.86$549,485.28  
10/18/2021Sharon MatesCEOSell8,192$40.00$327,680.00  
10/15/2021Sharon MatesCEOSell40,392$40.00$1,615,680.00  
6/14/2021Joel S MarcusDirectorSell18,289$42.27$773,076.0313,767  
5/27/2021Christopher D AlafiDirectorSell8,482$40.01$339,364.82346,795  
5/24/2021Christopher D AlafiDirectorSell26,575$40.47$1,075,490.25346,795  
5/21/2021Christopher D. AlafiDirectorSell1,100$40.00$44,000.00346,795  
2/19/2021Lawrence J HinelineCFOSell10,442$39.23$409,639.6610,442  
2/19/2021Mark NeumannEVPSell5,184$39.22$203,316.4850,523  
2/19/2021Sharon MatesCEOSell27,847$39.23$1,092,437.811,161,239  
2/19/2021Suresh K DurgamInsiderSell2,734$39.25$107,309.5025,838  
1/11/2021Lawrence J. HinelineCFOSell19,638$32.02$628,808.76  
1/11/2021Mark NeumannEVPSell9,684$32.02$310,081.6849,068  
1/11/2021Sharon MatesCEOSell41,896$32.01$1,341,090.961,175,288  
1/11/2021Suresh K DurgamInsiderSell4,367$32.12$140,268.0421,851  
1/4/2021Lawrence J HinelineCFOSell15,810$31.31$495,011.10
1/4/2021Michael HalsteadEVPSell16,160$31.30$505,808.00
1/4/2021Sharon MatesCEOSell48,341$31.30$1,513,073.30
11/17/2020Michael HalsteadEVPSell79,425$27.62$2,193,718.5079,425  
11/11/2020Lawrence J HinelineCFOSell28,034$25.41$712,343.9418,034  
11/4/2020Sharon MatesCEOSell50,000$25.00$1,250,000.001,163,392  
10/16/2020Mark NeumannEVPSell6,792$26.80$182,025.6034,912  
9/14/2020Christopher D AlafiDirectorBuy49,500$29.60$1,465,200.00345,223  
9/11/2020Christopher D AlafiDirectorBuy21,000$28.08$589,680.00
9/9/2020Lawrence J HinelineCFOSell41,983$31.14$1,307,350.6250,017  
5/13/2020Joel S MarcusDirectorSell7,297$20.63$150,537.1114,374  
5/11/2020Joel S MarcusDirectorSell50,000$19.95$997,500.0014,374  
1/9/2020Andrew SatlinEVPSell11,573$26.16$302,749.6822,911  
1/9/2020Lawrence J HinelineCFOSell19,638$26.16$513,730.0818,800  
1/9/2020Sharon MatesCEOSell41,895$26.16$1,095,973.201,204,707  
1/6/2020Michael HalsteadEVPSell21,458$30.34$651,035.7217,704  
1/6/2020Sharon MatesCEOSell45,598$30.28$1,380,707.441,182,366  
1/2/2020Michael HalsteadEVPSell7,807$32.43$253,181.017,998  
1/2/2020Sharon MatesCEOSell17,478$32.45$567,161.101,156,185  
10/16/2019Mark NeumannEVPSell6,774$8.25$55,885.5013,448  
9/10/2019Christopher D AlafiDirectorBuy485,000$10.26$4,976,100.00341,223  
8/30/2019Christopher D AlafiDirectorBuy125,000$8.52$1,065,000.00341,223  
6/12/2019Christopher D AlafiDirectorBuy170,000$11.73$1,994,100.00750,106  
5/14/2019Christopher D AlafiDirectorBuy100,000$12.56$1,256,000.00750,106  
2/27/2019Lawrence J HinelineCFOSell1,000$15.00$15,000.0025,832  
1/7/2019Kimberly E VanoverSVPSell592$12.29$7,275.6837,224  
1/7/2019Michael HalsteadEVPSell3,108$12.42$38,601.3624,757  
1/7/2019Sharon MatesCEOSell6,604$12.43$82,087.721,190,909  
1/4/2019Kimberly E VanoverSVPSell9,564$11.47$109,699.0837,224  
1/4/2019Michael HalsteadEVPSell21,458$11.46$245,908.6824,757  
1/4/2019Sharon MatesCEOSell45,598$11.45$522,097.101,190,909  
1/2/2019Lawrence J HinelineSVPSell7,807$11.09$86,579.6324,839  
1/2/2019Sharon MatesCEOSell17,478$11.09$193,831.021,156,185  
12/6/2018Robert E DavisSVPSell899$13.53$12,163.4731,155  
11/12/2018Joel S MarcusDirectorSell32,000$18.17$581,440.0021,671  
11/9/2018Joel S MarcusDirectorSell25,000$18.24$456,000.0021,671  
2/16/2018Lawrence J HinelineVPSell49,700$20.02$994,994.00  
1/22/2018Michael HalsteadSVPSell25,500$18.03$459,765.00191  
1/8/2018Kimberly E VanoverSVPSell772$17.46$13,479.1212,373  
1/8/2018Sharon MatesChairmanSell6,604$17.48$115,437.921,088,707  
1/5/2018Kimberly E VanoverSVPSell1,185$17.37$20,583.4526,803  
1/5/2018Sharon MatesChairmanSell11,257$17.08$192,269.561,099,964  
1/4/2018Lawrence J HinelineCFOSell3,192$15.67$50,018.6468,686  
12/29/2017Christopher D AlafiDirectorBuy1,001$14.48$14,494.48  
12/11/2017Richard A LernerDirectorSell7,000$15.09$105,630.008,621  
12/5/2017Robert E DavisSVPSell650$15.00$9,750.0028,514  
11/22/2017Christopher D AlafiDirectorBuy10,000$15.55$155,500.00744,466  
10/30/2017Sharon MatesCEOSell18,750$15.75$295,312.501,107,457  
10/2/2017Alafi Capital Co LlcMajor ShareholderBuy258,065$15.50$4,000,007.503,953,270  
1/5/2017Lawrence J HinelineVPSell1,918$16.58$31,800.4463,389  
1/5/2017Michael HalsteadSVPSell1,601$16.55$26,496.5521,506  
1/5/2017Sharon MatesChairmanSell4,081$16.55$67,540.551,088,707  
12/15/2016Kimberly E VanoverSVPSell9,375$15.23$142,781.255,000  
12/7/2016Alafi Capital Co LlcMajor ShareholderBuy65,000$16.27$1,057,550.003,674,379  
11/14/2016Christopher D AlafiDirectorBuy34,000$14.50$493,000.00730,529  
2/29/2016Christopher D AlafiDirectorBuy100,000$29.70$2,970,000.00728,828  
12/15/2015Lawrence J. HinelineCFOSell45,000$51.45$2,315,250.0062,200  
12/11/2015Sharon MatesCEOSell51,500$53.87$2,774,305.001,086,185  
12/8/2015Joel S MarcusDirectorSell92,700$54.47$5,049,369.0018,722  
11/24/2015Lawrence J HinelineCFOSell5,000$55.00$275,000.0059,700  
6/8/2015Lawrence P WennogleVPSell25,000$26.84$671,000.00  
3/11/2015Christopher D AlafiDirectorBuy625,000$24.00$15,000,000.00  
12/9/2014Lawrence J HinelineCFOSell22,500$16.71$375,975.00  
12/1/2014Moshe AlafiMajor ShareholderBuy1,422$14.75$20,974.50  
11/28/2014Christopher D AlafiDirectorBuy35,000$14.75$516,250.00  
11/19/2014Alafi Capital Co LlcMajor ShareholderBuy1,034$14.25$14,734.50  
11/18/2014Alafi Capital Co LlcMajor ShareholderBuy3,664$14.26$52,248.64  
11/13/2014Alafi Capital Co LlcMajor ShareholderBuy12,200$15.34$187,148.00  
11/6/2014Michael HalsteadSVPBuy20,000$15.38$307,600.00  
10/15/2014Lawrence P WennogleVPSell3,604$15.00$54,060.00  
10/13/2014Lawrence P WennogleVPSell1,600$15.00$24,000.00  
10/8/2014Lawrence P WennogleVPSell4,745$15.00$71,175.00  
10/6/2014Lawrence P WennogleVPSell16,499$15.00$247,485.00  
9/15/2014Lawrence P WennogleVPSell5,000$15.00$75,000.00  
9/8/2014Lawrence J HinelineCFOSell300$15.00$4,500.00  
5/22/2014Lawrence P WennogleVPSell6,000$15.00$90,000.00  
(Data available from 1/1/2013 forward)












Intra-Cellular Therapies (NASDAQ:ITCI) Insider Trade Frequently Asked Questions

Who is on Intra-Cellular Therapies's Insider Roster?

The list of insiders at Intra-Cellular Therapies includes Andrew Satlin, Christopher D Alafi, Joel S Marcus, Lawrence J Hineline, Mark Neumann, Michael Halstead, Rory B Riggs, Sharon Mates, and Suresh K Durgam. Learn more on insiders at ITCI.

What percentage of Intra-Cellular Therapies stock is owned by insiders?

13.20% of Intra-Cellular Therapies stock is owned by insiders. Learn more on ITCI's insider holdings.

Which Intra-Cellular Therapies insiders have been buying company stock?

The following insider purchased Intra-Cellular Therapies stock in the last 24 months: Christopher D Alafi ($2,054,880.00).

How much insider buying is happening at Intra-Cellular Therapies?

Insiders have purchased a total of 70,500 Intra-Cellular Therapies shares in the last 24 months for a total of $2,054,880.00 bought.

Which Intra-Cellular Therapies insiders have been selling company stock?

The following insiders have sold Intra-Cellular Therapies stock in the last 24 months: Christopher D Alafi ($1,414,855.07), Joel S Marcus ($1,595,676.03), Lawrence J Hineline ($13,019,007.54), Mark Neumann ($8,686,036.81), Michael Halstead ($11,111,130.78), Rory B Riggs ($5,087,501.84), Sharon Mates ($11,565,102.50), and Suresh K Durgam ($1,683,894.84).

How much insider selling is happening at Intra-Cellular Therapies?

Insiders have sold a total of 1,262,411 Intra-Cellular Therapies shares in the last 24 months for a total of $54,836,014.17 sold.

This page was last updated on 5/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.